Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looking good here
MUST READ Why today could be a life changer,.. i am not a helpless pumper just saying there is a valid chance today could be a life changer
Everyone saw yesterday MM's had no shares after doing much DD and speaking to other this is probably due to A. practically all the shares being restricted by a the Pharma CO. that is holding all the co. debt or if it's not restricted the pharma co. is in the process of buying out the co. therefore the TA has no stock insists in transfer a few ppl could not get straight info from TA even though they admit the TA is not gagged from the company...The fact there have been zero updates from the company and years yet they are still current on fillings and have active employees (see my previous post on the board and search linkedin for current employees, not secretaries MIT GRads and harvard professors) they company headquarters are on Harvard campus! the CEO is on board of Raptor Pharma (NSDQ) and owns tarixpharma (www.tarixpharma.com) no pr updates but ceo insisted very confidently "we are very very active" this is no scam they have a one of its kind 1st to mkt regenerative process to help cure liabilities this smells like buyout all over the place the only MM i saw yesterday was WABR (never seen such a MM before) ran out of shares at .006 and is currently on the BID (pre-mkt) along with NITE....I am not saying this will run up to .30 (where the ask is now stacked) but it definitely could end of day there was a real 300K bid at .02...something is up people one thing i know for sure is this is no dead shell scam CEO and board are literally top in their field and he wouldn not give me any specific info on phone even though I was begging Do some more DD yourselves most shares yesterday were bought well over a penny and a intra-day of .05....this could be EPIC
Can you spell out your thoughts for the u enlightened r u saying a buyout ?
All shares are restricted MMs have NONE that is not a exaggeration anyone watching level 2 saw this
Ceo and board are all top professors at Harvard MIT this is real ppl
HUGE DD aside from the MMs literally having no shares this is a total legit company with cutting edge stuff
check out the all-star leaders of Pathfinder their board reads like a top nasdaq company seriously mind blowing stuff...
Also their corprate headquarters are located on Harvard Campus!
http://www.pathfindercelltherapy.com/management-and-board/
CEO Rich Franklin is on the board of Raptor Pharma a Nasdaq Company trading now in the 9$ range he also is the CEO of Tarix Pharma and Tarix Orhpan http://www.tarixpharma.com/ both these companies are filled with top doctors from Harvard and MIT
Brock Reeve, Director
Brock is a graduate of Yale and the Harvard Business School, and is Executive Director of the Harvard Stem Cell Institute. HSCI is comprised of the schools of Harvard University and all its affiliated hospitals and research institutions. The institute currently has 75 principal faculty and 140 affiliated faculty...
PFND is on its way to a potential cure of diabities...
John Brooks III, Director
John is the CEO of the Joslin Diabetes Center. He is the founder of Healthcare Capital Consulting LLC, an advisory services and consulting firm that consults with life science companies, especially early stage start-ups that are seeking strategic advice as well as access to capital to initiate, develop and grow their businesses. John is a founding partner of PrismVentureworks, which is based in Needham, Massachusetts. Prism raised over $1.25B over a twelve year span, of which one-third was targeted in the life sciences sector. John sits on the board of a number of early stage companies, and he is the CEO of Reflectance Medical, a noninvasive tissue perfusion start-up. John was formerly a General Manager at Pfizer/Valleylab in Boulder, Colorado where he developed and executed a successful minimally invasive surgery business and managed an energy based emerging businesses strategy. Prior to that, he was the general manager and president of Pfizer/Strato Medical, a rapidly evolving vascular access medical device business. John has co-founded three paradigm shifting life sciences companies, Songbird Hearing, Locus Pharmaceuticals and Insulet (PODD).
John is a biotechnology advisory board member for Draper Laboratory, the Pittsburgh Life Sciences Greenhouse, the Massachusetts Technology Transfer Council, and the Kansas Heartland Bioventures Fund. He is the Chairman of the Board of Trustees of the Joslin Diabetes Center. John is also a member of M2D2, an early stage medical technology accelerator and a board member of Mass Medic’s Ignite entrepreneurial center as well a member of the CIMIT Technology Advisory Group, the Harvard Medical Cooperative, and he is a Senior Advisor to Johnston Blakely, a life sciences investment banking firm....
Zen Chu, Director
Zen is the founder of Accelerated Medical Ventures and works as a cofounder, adviser and investor in early stage medical device, consumer healthcare, and connected health ventures. Prior to AMV, he served as the founding Director of Business Development for the Wyss Institute at Harvard Medical School and their internal Accelerator Venture Fund. Earlier, Zen co-founded 3DM Biomaterials along with a group of MIT scientists, serving as the CEO of the venture-backed regenerative medicine company for five years before selling it in 2008. In Silicon Valley, Zen created and directed Hewlett Packard’s HPGarage new technology ventures program. He has also served as an advisor on healthcare innovation to Brigham & Women’s Hospital, Cleveland Clinic, and the Harvard-MIT Division of Health Sciences & Technology (HST). Zen earned a BS in Biomedical/Electrical Engineering from Southern Methodist University and a Masters of Business Administration from Yale University.
John Alam, M.D., Director
John is Head of the Therapeutic Strategic Area for Diseases of Aging for Sanofi--Aventis. He is a biopharmaceutical R & D executive who currently advises a number of non-profit organizations and biotechnology companies, including as Senior Medical Advisor to a publicly traded anti-virals company, Inhibitex, Inc. and as an Entrepreneur-in-Residence at a Boston-area venture capital firm. He is also on the executive committee of NEWDIGS, a multi-stake holder public policy-oriented consortium led by the Center for Biomedical Innovation at the Massachussetts Institute of Technology (MIT) to re-design the pharmaceutical development process.
Previously, John played major instrumental roles in the growth and development of two of the top ten US biotechnology companies, Vertex Pharmaceuticals and Biogen (now Biogen Idec). Through to 2008, he was the Executive Vice President, Medicines Development and the Chief Medical Officer for Vertex Pharmaceuticals. In that role, he led regulatory affairs, clinical development, clinical pharmacology, pharmacovigilance, medical affairs, and toxicology. Among other accomplishments at Vertex, he built and led the organization that progressed a major advance in the treatment of hepatitis C, telaprevir (leading hepatitis C protease inhibitor), from pre-clinical development to phase 3 clinical studies. From 1991 to 1997, he led the clinical development from phase 2 to registration and market launch in US and EU of Avonexâ (interferon beta-1a treatment for multiple sclerosis), Biogen’s first commercialized and the leading therapy for multiple sclerosis in the US.
Prior to joining the biopharmaceutical industry, John completed an internal medicine residency at The Brigham and Women’s Hospital and a research fellowship at the Dana-Farber Cancer Institute. He holds an M.D. from Northwestern University Medical School and an S.B. in chemical engineering from MIT.
Preferred stock, $.01 par value; shares authorized - 5,000; issued and outstanding - none
Common stock, $.001 par value; shares authorized - 1,000,000 issued and outstanding - 667,162 and
667,162 at September 30, 2014 and December 31, 2013, respectively 667 667
filing clearly says all number are in thousands except for share number
IMO there is two options one by some crazy accounting error there is really 1 million authorized or 2 there are a TON of restriced shares like tons...either way this float is tiny...trying very hard to get exact numbers any one with ideas on helping out please let figure it out huge money can be made here
As of last filing CUrren Authorized is one million shares 671k o/s some say it is missing a zero and is 671 million def not true a 671 million share stock won't move 5000% on 4 mil shares impossible
There is quite literally nothing on the ask 389k bidder right before close retest of the .05 high early tmrw
My boys Are working on it will have soon last filing says it's one million shares
Company headquarters is in Harvard campus
No you didn't I did see @pennycheck feed on Twitter alerted at .0015 with dd
Call the ceo dudes he picked on first ring
Lol makes more sense but it's up 920% on 2.6 mil shares
Latest filing shows a 1 mil a/s
Website updated today 1st time in yrs called ceo picked up right away ;)
They just updated otc markets 20 mil float as of TODAY
He is working on filings and finalizing deals with distributors before a full blown or coming shortly
New ceo responds to emails....just sayin :)
Crazy thin the right news will send it nutso
Full dd posted yesterday THP blog thehonestpenny.blogspot.com
Pretty sure we retest highs into close for a or Monday gap and run over penny
Updated 180 mm float 2000 current shareholders
Reselling used electronics
Most def hearing PRs and filings coming next week
hearing prs and filings monday here is brand new CEO's background
from bloomberg.com
http://www.bloomberg.com/research/stocks/private/person.asp?personId=378671&privcapId=378663
Mr. Thomas J. Beener has been Chief Executive Officer of Greenland Corporation since 2001, General Counsel and Secretary since 1998 and serves as Chairman of the Board, President, and Chief Accounting Officer. Mr. Beener joined Greenland Corp. in 1998 as General Counsel and Secretary. Mr. Beener has an extensive background in securities law. He served as Acing Chief Financial Officer of Greenland Corp. He is a Corporate and Securities Attorney with experience in public company counsel work, corporate, public offerings and private placements, securities compliance, mergers and acquisitions, technology licensing agreements, and broker dealer compliance and operations. Mr. Beener founded, and for nine years managed, an NASD Broker and Dealer firm and has served as in-house counsel and corporate Secretary to a NASDAQ listed companies. He has been Director of Greenland Corp. since January 1999. He served as member of board of Directors to NASDAQ listed companies. He served as Director of Medina International Holdings, Inc. from October 21, 2010 to November 1, 2010.Mr. Beener has a juris doctorate degree from the University Gonzaga Law School.
why this popped
OTCmarkets info updated r/m here
click link for pic
click me
this is not a random pump check the gtrl otc markets site was completely updated last night with a ceo chairman address business description accountant lawyers only thing the same is the float round 2 on this stock should be amazing
Link ? Also when is court date ? Any links will be helpful
Loaded up today
Extremely oversold gem here 187 float and 10 million in assets!!! No stock with such a float comes close to this
Been waiting for Months for the big boys to come on here take off imminent love the float 10 mil assets
Zero dilution no mms insanely thin level 2 confirmed 46 mil float no resistance on chart dist. News coming y oh y would u short this lmao
Also have not seen one drop of dilution diver I started watching this one (last 5 weeks)
Would not want to be caught short on such a tiny floater with news pending very soon perjuvenol website is getting updated twice daily realy product and distribution deals coming
Getting ready this run will be epic
Shorty getting scared lol
Per ceo email updates following news coming shortly 1.audited filings 2.full launch of miles for Bitcoin website 3. 5 more Bitcoin atm installations 4.mj dispensary Bitcoin in Detroit areas 5.name change 6. Name change 7. National tv branding on ufc pro fighters And dillution is DONE Vfin gone all week
One tick flippers thinking this a quick momo play next week news filings is when this thing STARTS mark my words
Glad to have you on board crazy thin gonna get explosive soon